Clinical Trial Update: An Investigation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2245035 in Healthy Volunteers and Allergic Rhinitics. [Phase 1]

View source ↗

Summary

A Phase 1 study assessing safety, tolerability, PK and PD of GSK2245035 in healthy volunteers and individuals with seasonal allergic rhinitis; the trial has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• GSK2245035 (GSK2245035)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Seasonal | Phase 1 | Status: COMPLETED